• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis.接受强化抗血栓预防的COVID-19患者的出血发生率
J Thromb Thrombolysis. 2020 Nov;50(4):833-836. doi: 10.1007/s11239-020-02244-y.
2
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report.血友病 A 如何影响严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）治疗：一例报告。
J Thromb Thrombolysis. 2020 Nov;50(4):795-798. doi: 10.1007/s11239-020-02227-z. Epub 2020 Jul 16.
3
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.血栓预防：在 COVID-19 大流行期间平衡证据和经验。
J Thromb Thrombolysis. 2020 Nov;50(4):799-808. doi: 10.1007/s11239-020-02231-3.
4
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.危重症 COVID-19 患者接受预防性或治疗性抗凝治疗时的静脉血栓栓塞症：系统评价和荟萃分析。
J Thromb Thrombolysis. 2020 Nov;50(4):814-821. doi: 10.1007/s11239-020-02235-z.
5
[What I talk about when I talk about COVID-19].当我谈论新冠病毒时我在谈些什么
Laeknabladid. 2020 Sep;106(9):395. doi: 10.17992/lbl.2020.09.594.
6
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.阿加曲班治疗1例2019冠状病毒病患者的肝素诱导的血小板减少症
J Thromb Thrombolysis. 2020 Nov;50(4):1012-1014. doi: 10.1007/s11239-020-02248-8. Epub 2020 Aug 11.
7
Effect of Gastrointestinal Symptoms in Patients With COVID-19.新型冠状病毒肺炎患者胃肠道症状的影响
Gastroenterology. 2020 Jun;158(8):2294-2297. doi: 10.1053/j.gastro.2020.03.020. Epub 2020 Mar 19.
8
COVID-19 and the Forgotten Majority.新冠疫情与被遗忘的大多数
High Blood Press Cardiovasc Prev. 2020 Oct;27(5):339. doi: 10.1007/s40292-020-00407-9. Epub 2020 Aug 29.
9
In Defense of Our Patients: Indirect Negative Neurological Consequences of SARS-CoV-2 in the New York Epicenter.为我们的患者辩护：纽约疫情中心SARS-CoV-2的间接负面神经后果
J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105127. doi: 10.1016/j.jstrokecerebrovasdis.2020.105127. Epub 2020 Jul 10.
10
Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?血流动力学不稳定的新冠肺炎合并急性肺栓塞患者的纤溶治疗：是或否？
J Thromb Thrombolysis. 2020 Jul;50(1):221-222. doi: 10.1007/s11239-020-02131-6.

引用本文的文献

1
Association between antithrombotic therapy and mortality in patients hospitalized for COVID‑19.抗血栓治疗与因 COVID-19 住院患者死亡率之间的关联。
Thromb J. 2024 Jan 4;22(1):5. doi: 10.1186/s12959-023-00572-6.
2
COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.新型冠状病毒肺炎相关静脉血栓栓塞症：复发风险与大出血风险
Res Pract Thromb Haemost. 2023 Sep 20;7(7):102206. doi: 10.1016/j.rpth.2023.102206. eCollection 2023 Oct.
3
Spontaneous bleeding in COVID-19: A retrospective experience of an Italian COVID-19 hospital.新型冠状病毒肺炎中的自发性出血：一家意大利新型冠状病毒肺炎医院的回顾性经验
SA J Radiol. 2022 Oct 31;26(1):2509. doi: 10.4102/sajr.v26i1.2509. eCollection 2022.
4
Does High-Dose Thromboprophylaxis Improve Outcomes in COVID-19 Patients? A Meta-analysis of Comparative Studies.高剂量血栓预防能否改善COVID-19患者的预后？一项比较研究的荟萃分析。
TH Open. 2022 Oct 19;6(4):e323-e334. doi: 10.1055/a-1930-6492. eCollection 2022 Oct.
5
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study.新型冠状病毒肺炎住院患者大出血的发生率、危险因素及临床影响：CLOT-COVID研究的亚组分析
Thromb J. 2022 Sep 20;20(1):53. doi: 10.1186/s12959-022-00414-x.
6
Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population-Bleeding Risk Factors in COVID-19 Patients.住院COVID-19患者出血风险评估：一家三级医院在疫情期间针对主要少数民族人群的经验——COVID-19患者的出血风险因素
J Clin Med. 2022 May 13;11(10):2754. doi: 10.3390/jcm11102754.
7
Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.危重症COVID-19患者的抗凝策略与出血事件风险
Med Intensiva. 2023 Jan;47(1):1-8. doi: 10.1016/j.medin.2021.07.004. Epub 2021 Jul 30.
8
Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study.COVID-19患者中普通肝素治疗的管理：一项回顾性队列研究。
Res Pract Thromb Haemost. 2021 May 7;5(4):e12521. doi: 10.1002/rth2.12521. eCollection 2021 May.
9
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis.危重症 COVID-19 患者静脉血栓栓塞症的患病率：系统评价与荟萃分析
Front Cardiovasc Med. 2021 Jan 8;7:598846. doi: 10.3389/fcvm.2020.598846. eCollection 2020.

本文引用的文献

1
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
2
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
3
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
4
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
5
COVID-19 and its implications for thrombosis and anticoagulation.新型冠状病毒肺炎及其对血栓形成和抗凝的影响。
Blood. 2020 Jun 4;135(23):2033-2040. doi: 10.1182/blood.2020006000.
6
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
7
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.抗凝治疗的重症 COVID-19 患者中静脉血栓栓塞事件发生率高。
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
8
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
9
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
10
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis.

作者信息

Kessler Chiara, Stricker Hans, Demundo Daniela, Elzi Luigia, Monotti Rita, Bianchi Giorgia, Llamas Michael, Spinedi Luca, Rossi Davide, Chiesa Alessandro Felice, Pagnamenta Alberto, Conti Marco, Casso Gabriele, Stoira Elisa, Valenti Elisa, Colucci Giuseppe, Stussi Georg, Gerber Bernhard, Previsdomini Marco

机构信息

Clinic of Hematology, Oncology Institute of Southern Switzerland, 6500, Bellinzona, Switzerland.

Department of Angiology, Ospedale La Carità, Locarno, Switzerland.

出版信息

J Thromb Thrombolysis. 2020 Nov;50(4):833-836. doi: 10.1007/s11239-020-02244-y.

DOI:10.1007/s11239-020-02244-y
PMID:32803737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7427750/
Abstract
摘要